Envoy Medical (COCH) Short term Debt (2021 - 2023)

Envoy Medical has disclosed Short term Debt across 3 years of filings, most recently posting $311000.0 for Q4 2023.

• Short term Debt for Q4 2023 came in at $311000.0, down 7.16% year-over-year; the trailing twelve-month figure through Dec 2023 was $311000.0 (down 7.16% YoY), and the FY2023 annual result was $311000.0, down 7.16% from the prior year.
• Short term Debt came in at $311000.0 for Q4 2023 at Envoy Medical, up from $228000.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $335000.0 in Q4 2022 to a low of $13803.0 in Q1 2021.
• The 3-year median for Short term Debt is $228000.0 (2023), against an average of $214676.6.
• Peak annual rise in Short term Debt reached 7.16% in 2023, while the deepest fall reached 7.16% in 2023.
• Envoy Medical's Short term Debt stood at $185580.0 in 2021, then surged by 80.52% to $335000.0 in 2022, then slipped by 7.16% to $311000.0 in 2023.
• The last three Short term Debt figures came in at $311000.0 (Q4 2023), $228000.0 (Q3 2023), and $335000.0 (Q4 2022), per Business Quant data.